期刊文献+
共找到810篇文章
< 1 2 41 >
每页显示 20 50 100
Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways 被引量:1
1
作者 Liu Shi Li Zhou +13 位作者 Ming Han Yu Zhang Yang Zhang Xiao-Xue Yuan Hong-Ping Lu Yun Wang Xue-Liang Yang Chen Liu Jun Wang Pu Liang Shun-Ai Liu Xiao-Jing Liu Jun Cheng Shu-Mei Lin 《World Journal of Gastroenterology》 SCIE CAS 2023年第18期2798-2817,共20页
BACKGROUND Hepatic fibrosis is a serious condition,and the development of hepatic fibrosis can lead to a series of complications.However,the pathogenesis of hepatic fibrosis remains unclear,and effective therapy optio... BACKGROUND Hepatic fibrosis is a serious condition,and the development of hepatic fibrosis can lead to a series of complications.However,the pathogenesis of hepatic fibrosis remains unclear,and effective therapy options are still lacking.Our group identified hepatitis C virus nonstructural protein 3-transactivated protein 1(NS3TP1) by suppressive subtractive hybridization and bioinformatics analysis,but its role in diseases including hepatic fibrosis remains undefined.Therefore,additional studies on the function of NS3TP1 in hepatic fibrosis are urgently needed to provide new targets for treatment.AIM To elucidate the mechanism of NS3TP1 in hepatic fibrosis and the regulatory effects of calcitriol on NS3TP1.METHODS Twenty-four male C57BL/6 mice were randomized and separated into three groups,comprising the normal,fibrosis,and calcitriol treatment groups,and liver fibrosis was modeled by carbon tetrachloride(CCl4).To evaluate the level of hepatic fibrosis in every group,serological and pathological examinations of the liver were conducted.TGF-β1 was administered to boost the in vitro cultivation of LX-2 cells.NS3TP1,α-smooth muscle actin(α-SMA),collagen I,and collagen Ⅲ in every group were examined using a Western blot and real-time quantitative polymerase chain reaction.The activity of the transforming growth factor beta 1(TGFβ1)/Smad3 and NF-κB signaling pathways in each group of cells transfected with pcDNA-NS3TP1 or siRNA-NS3TP1 was detected.The statistical analysis of the data was performed using the Student’s t test.RESULTS NS3TP1 promoted the activation,proliferation,and differentiation of hepatic stellate cells(HSCs)and enhanced hepatic fibrosis via the TGFβ1/Smad3 and NF-κB signaling pathways,as evidenced by the presence of α-SMA,collagen I,collagen Ⅲ,p-smad3,and p-p65 in LX-2 cells,which were upregulated after NS3TP1 overexpression and downregulated after NS3TP1 interference.The proliferation of HSCs was lowered after NS3TP1 interference and elevated after NS3TP1 overexpression,as shown by the luciferase assay.NS3TP1 inhibited the apoptosis of HSCs.Moreover,both Smad3 and p65 could bind to NS3TP1,and p65 increased the promoter activity of NS3TP1,while NS3TP1 increased the promoter activity of TGFβ1 receptor I,as indicated by coimmunoprecipitation and luciferase assay results.Both in vivo and in vitro,treatment with calcitriol dramatically reduced the expression of NS3TP1.Calcitriol therapy-controlled HSCs activation,proliferation,and differentiation and substantially suppressed CCl4-induced hepatic fibrosis in mice.Furthermore,calcitriol modulated the activities of the above signaling pathways via downregulation of NS3TP1.CONCLUSION Our results suggest that calcitriol may be employed as an adjuvant therapy for hepatic fibrosis and that NS3TP1 is a unique,prospective therapeutic target in hepatic fibrosis. 展开更多
关键词 Nonstructural protein 3-transactivated protein 1 calcitriol Liver fibrosis Hepatic stellate cells Mouse model TGFβ1/Smad3 NF-κB Signaling pathway
下载PDF
Calcitriol induces post-thawed bovine sperm capacitation
2
作者 ANA CECILIA LIAUDAT FRANCISCA EBEL +4 位作者 BIANCA ANA OPIZZO MARINA AURORA GONZALEZ DAMIÁN BLOIS PABLO BOSCH NANCY RODRIGUEZ 《BIOCELL》 SCIE 2023年第5期1135-1143,共9页
Background:Capacitation is a set of physiological changes sperms undergo to acquire fertilizing capacity.In vivo,this process is directly associated with high calcium levels in sperm cytoplasm.Calcitriol,the vitamin D... Background:Capacitation is a set of physiological changes sperms undergo to acquire fertilizing capacity.In vivo,this process is directly associated with high calcium levels in sperm cytoplasm.Calcitriol,the vitamin D hypercalcemic metabolite,is related to human sperm motility,capacitation,and acrosome reaction.This work aimed to study the effect of calcitriol on bull sperm quality parameters and capacitation.Methods:One million freezethawed spermatozoa were obtained from different bulls and treated with 20 nM of calcitriol for 30 min.Untreated cells(negative control)and treated ones with calcitriol or heparin(100μg/mL,positive capacitation control)were evaluated for motility,viability,and functional parameters.Menadione(70μM,30 min)treatment was included as a reactive oxygen species(ROS)positive sperm agent.Results:The results elucidated that sperm exposed to 20 nM calcitriol showed higher viability,vigor,and capacitation than their positive and negative controls.The percentage of sperm with intact plasma and acrosome membranes,mitochondrial membrane potential(ΔΨm),and phosphatidylserine externalization was similar in all the conditions evaluated,while ROS production was higher with heparin and menadione-treated groups than the calcitriol group or negative control.Conclusion:Our results indicate that calcitriol induces the capacitation of thawed bull spermatozoa and maintains acceptable values of progressive motility,viability,and vigor without altering key biological parameters such as redox status,ΔΨm,and cell death. 展开更多
关键词 BOVINE Sperm capacitation calcitriol Cell viability Plasma membrane integrity Reactive oxygen species
下载PDF
Calcitriol induced hypercalcemia-a rare phenomenon in lung cancer:A case report
3
作者 Amulya Prakash Farhan Khalid +3 位作者 Ahmad Alalwan Husam Bader Doantrang Du Trishala Meghal 《World Journal of Clinical Oncology》 2023年第11期544-548,共5页
BACKGROUND Calcitriol-induced hypercalcemia has been rarely reported in cases of lung cancer;however,it is frequently reported in cases of lymphoid malignancy and granulomatous disease.We present a rare case of hyperc... BACKGROUND Calcitriol-induced hypercalcemia has been rarely reported in cases of lung cancer;however,it is frequently reported in cases of lymphoid malignancy and granulomatous disease.We present a rare case of hypercalcemia associated with squamous cell cancer of the lung with elevated calcitriol level.CASE SUMMARY A 61-year-old Caucasian female with severe hypercalcemia of 15 mg/dL,which led to a new diagnosis of metastatic lung cancer.Since the parathyroid hormonerelated peptide(PTHrP)level was minimally elevated at 2.1 pmol/L,we believe excessive calcitriol production by tumor cells was the underlying mechanism for hypercalcemia.Calcitriol was significantly elevated at 130 pg/mL with a low 25-hydroxyvitamin D level of 25.9 ng/mL and suppressed PTH level of 8 pg/mL.Corticosteroids are generally used to treat calcitriol-induced hypercalcemia,but we successfully treated our patient with bisphosphonate,highlighting the further utility of bisphosphonates in hypercalcemia treatment.CONCLUSION We believe that the underlying cause of hypercalcemia,in this case of metastatic squamous cell lung carcinoma,was elevated calcitriol,which was likely produced by the tumor cells.In addition to PTHrP,calcitriol levels should be included in the workup for hypercalcemia in cases of lung cancer.However,the pathophysiology and prognostic significance of dysregulated calcitriol production in solid tumors remain unclear and warrant further research.Bisphosphonate may be used as a steroid-sparing therapy even in cases of calcitriol-induced hypercalcemia and warrants further investigation. 展开更多
关键词 Hypercalcemia associated malignancy Lung cancer DENOSUMAB calcitriol Vitamin D Case report
下载PDF
Solid lipid dispersion of calcitriol with enhanced dissolution and stability 被引量:2
4
作者 Ting Yuan Lingzhen Qin +4 位作者 Zhouhua Wang Jinyuan Nie Zhefei Guo Ge Li Chuanbin Wu 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2013年第1期39-47,共9页
Solid dispersion of calcitriol with lipophilic surfactants and triglycerides was developed by melt-mixing method to modify the release and enhance stability of the drug.The solid dispersions were characterized by diff... Solid dispersion of calcitriol with lipophilic surfactants and triglycerides was developed by melt-mixing method to modify the release and enhance stability of the drug.The solid dispersions were characterized by differential scanning calorimetry(DSC),hot stage polarized optical microscopy(HSPM),infrared spectroscopy(FTIR)and stability studies.The solid dispersion significantly enhanced the stability of calcitriol,which could be attributed to the high antioxidant activity of the solid lipid dispersion.The rapid dissolution rate from the solid dispersion was attributed to the amorphous or solid solution state of drug with improved specific surface area and wettability than the drug crystals.Therefore,solid dispersion of calcitriol with D-a-tocopheryl polyethylene glycol 1000 succinate(TPGS)offers a good approach to modify the release and enhance stability of calcitriol.The influence of lipophilic solid dispersion on drug bioavailability needs further investigation. 展开更多
关键词 calcitriol Solid dispersion TPGS STABILITY
下载PDF
Effect of Sevelamer Hydrochloride on the Serum Calcitriol Concentration in Hemodialysis Patients 被引量:1
5
作者 Kazumichi Matsushita Keitaro Sato +2 位作者 Kohei Unagami Kosaku Nitta Kiichiro Tago 《International Journal of Clinical Medicine》 2014年第20期1320-1327,共8页
Back ground: There are no published clinical data in hemodialysis (HD) patients with mineral bone disorder (CKD-MBD) regarding the effect of sevelamer hydrochloride on the absorption of the oral calcitriol. Objectives... Back ground: There are no published clinical data in hemodialysis (HD) patients with mineral bone disorder (CKD-MBD) regarding the effect of sevelamer hydrochloride on the absorption of the oral calcitriol. Objectives: The aim of the present study was to determine the association of the sevelamer hydrochloride and serum 1-25(OH)2D concentration during oral calcitriol therapy. Methods: This was a before-and-after study in HD patients. Forty-six patients co-administered with phosphate-binder and calcitriol for CKD-MBD therapy took lanthanum carbonate (LC) and sevelamer hydrochloride (SH) for 4 weeks, respectively with calcitriol. The serum 1-25(OH)2D concentration was assessed after each period. Results: Serum 1-25(OH)2D concentration was significantly reduced with co-administration of SH compared to LH (mean, calcitriol with LC→SH: 19.9 pg/ml → 14.2 pg/ml, p 2D concentrations after oral calcitriol administration compared to LH in HD patients. When we use SH as a phosphate binder with calcitriol for HD patients with CKD-MBD, we should consider the inhibitory effect of SH on oral calcitriol absorption. 展开更多
关键词 HEMODIALYSIS calcitriol SEVELAMER Hydrochrolide LANTHANUM CARBONATE BIOAVAILABILITY
下载PDF
The study of calcitriol,cinacalcet combined with nursing intervention effect of SHPT, calcium, phosphorus metabolism and parathyroid hormone on MHD patients
6
作者 Le Chen Xiao-Yun Wu 《Journal of Hainan Medical University》 2017年第6期45-47,共3页
Objective:To investigate calcitriol, cinacalcet plus comprehensive intervention on maintenance hemodialysis (MHD) patients with secondary hyperparathyroidism (SHPT) calcium (Ca), phosphorus (P) metabolism and parathyr... Objective:To investigate calcitriol, cinacalcet plus comprehensive intervention on maintenance hemodialysis (MHD) patients with secondary hyperparathyroidism (SHPT) calcium (Ca), phosphorus (P) metabolism and parathyroid hormone (PTH) effect.Methods: A total of 80 cases of patients with SHPT from January 2014 to January 2016 in our hospital were randomly divided into observation group and control group, control group to eat the whole piece of cinacalcet hydrochloride oral tablets, the initial dose of 25 mg/d, every 2 to 4 weeks, according to Ca×P, parathyroid hormone (iPTH) test results adjust the dose, the maximum dose of not more than 75 mg/d, the observation group in the control group on the basis of oral administration of Calcitriol Soft Capsules 0.25 g/d, 3 times/week, 2 groups were given comprehensive intervention measures, to evaluate the curative effect after 3 months of treatment. The 2 groups before and after treatment collected fasting peripheral venous blood, the determination of Ca, P and alkaline phosphatase by colorimetric method (ALP), Ca, P product calculation (Ca×P), to detect the level of iPTH before and after treatment by ELISA method;TY-6858-HI type ultrasound instrument, measuring length, width and thickness of the parathyroid glands, and calculate the parathyroid gland volume.Results:in the observation group after treatment, Ca, Ca×P increased degree, P, ALP, iPTH lower than the control group, the size of the parathyroid gland was better than the control group.Conclusion:calcitriol, cinacalcet combined intervention therapy has good clinical effect in patients with MHD SHPT, Ca, P can effectively improve the metabolism, reduce the level of iPTH, reduce the parathyroid gland volume is worthy of promotion. 展开更多
关键词 calcitriol CINACALCET NURSING intervention MHD SHPT CALCIUM Phosphorus Parathyroid hormone
下载PDF
Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype 被引量:4
7
作者 Ulrike G Strauch Florian Obermeier +6 位作者 Nicole Grunwald Nadja Dunger Heiko C Rath Jürgen Schlmerich A Steinmeyer U Zügel HH Herfarth 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第48期6529-6537,共9页
AIM: To investigate the effects of ZK1916784, a low calcemic analog of calcitriol on intestinal inflammation. METHODS: Acute and chronic colitis was induced by dextran sodium sulfate (DSS) according to standard proced... AIM: To investigate the effects of ZK1916784, a low calcemic analog of calcitriol on intestinal inflammation. METHODS: Acute and chronic colitis was induced by dextran sodium sulfate (DSS) according to standard procedures. Mice were treated intraperitoneally with ZK1916784 or placebo and colonic inflammation was evaluated. Cytokine production by mesenterial lymph node (MLN) cells was measured by ELISA. Immunohistochemistry was performed to detect intestinal dendritic cells (DCs) within the colonic tissue, and the effect of the calcitriol analog on DCs was investigated. RESULTS: Treatment with ZK191784 resulted in significant amelioration of disease with a reduced histological score in acute and chronic intestinal inflammation. In animals with acute DSS colitis, down- regulation of colonic inflammation was associated with a dramatic reduction in the secretion of the proinflammatory cytokine interferon (IFN)-γ and a significant increase in intereleukin (IL)-10 by MLN cells. Similarly, in chronic colitis, IL-10 expression in colonic tissue increased 1.4-fold when mice were treated with ZK191784, whereas expression of the Th1-specific transcription factor T-beta decreased by 81.6%. Lower numbers of infiltrating activated CD11c+ DCs were found in the colon in ZK191784-treated mice with acute DSScolitis, and secretion of proinflammatory cytokines by primary mucosal DCs was inhibited in the presence of the calcitriol analog. CONCLUSION: The calcitriol analog ZK191784 demonstrated significant anti-inflammatory properties in experimental colitis that were at least partially mediated by the immunosuppressive effects of the derivate on mucosal DCs. 展开更多
关键词 右旋糖苷 硫酸钠 大肠炎 树状细胞
下载PDF
Calcitriol-induced hypercalcemia in a patient with granulomatous mycosis fungoides and end-stage renal disease
8
作者 Takamasa Iwakura Naro Ohashi +11 位作者 Naoko Tsuji Yoshitaka Naito Shinsuke Isobe Masafumi Ono Tomoyuki Fujikura Takayuki Tsuji Yukitoshi Sakao Hideo Yasuda Akihiko Kato Toshiharu Fujiyama Yoshiki Tokura Yoshihide Fujigaki 《World Journal of Nephrology》 2013年第2期44-48,共5页
An 86-year-old man, diagnosed as having mycosis fungoides in May 2008 and treated with repeated radiation therapy, was admitted to our hospital for initiation of hemodialysis due to end-stage renal disease(ESRD) in Ap... An 86-year-old man, diagnosed as having mycosis fungoides in May 2008 and treated with repeated radiation therapy, was admitted to our hospital for initiation of hemodialysis due to end-stage renal disease(ESRD) in April 2012. On admission, his corrected serum calcium level was 9.3 mg/d L, and his intact parathyroid hormone level was 121.9 pg/mL(normal range 13.9-78.5pg/mL), indicating secondary hyperparathyroidism due to ESRD. After starting hemodialysis, urinary volume diminished rapidly. The serum calcium level increased(12.7 mg/dL), and the intact parathyroid hormone level was suppressed(< 5 pg/m L), while the 1,25-dihy-droxyvitamin D3(calcitriol) level increased(114 pg/mL, normal range: 20.0-60.0 pg/m L) in June 2012. The possibilities of sarcoidosis and tuberculosis were ruled out. Skin biopsies from tumorous lesions revealed a diagnosis of granulomatous mycosis fungoides. The serum soluble interleukin-2 receptor levels and the degrees of skin lesions went in parallel with the increased serum calcium and calcitriol levels. Therefore, the patient was diagnosed as having calcitriol-induced hypercalcemia possibly associated with granulomatous mycosis fungoides. Granulomatous mycosis fungoides is rare, and its association with calcitriol-induced hypercalcemia has not been reported. Careful attention to calcium metabolism is needed in patients with granulomatous mycosis fungoides, especially in patients with ESRD. 展开更多
关键词 血液透析 肾病 治疗方法 临床分析
下载PDF
骨化三醇与益生菌对帕金森小鼠模型行为学影响的对照研究
9
作者 刘慧琴 杨娟 《贵州医药》 CAS 2024年第3期345-350,共6页
目的探究骨化三醇、益生菌对帕金森病(PD)小鼠模型行为学的影响。方法雄性SPF级健康C57BL/6小鼠45只,随机分为A组(正常对照,n=5)、B1组(PD模型对照,n=10)、B2组(PD模型益生菌干预,n=10)、B3组(PD模型骨化三醇干预,n=10),B4组(PD模型益... 目的探究骨化三醇、益生菌对帕金森病(PD)小鼠模型行为学的影响。方法雄性SPF级健康C57BL/6小鼠45只,随机分为A组(正常对照,n=5)、B1组(PD模型对照,n=10)、B2组(PD模型益生菌干预,n=10)、B3组(PD模型骨化三醇干预,n=10),B4组(PD模型益生菌联合骨化三醇干预,n=10)。每组均连续喂养3个月,比较5组小鼠喂养后15 d、1个月、2个月及3个月的行为学变化。结果爬杆实验中从小球上下来的计分:时间、干预方法在实验分值上存在统计学差异(P<0.05),B1组、B2组、B3组与B4组相比,存在统计学差异(P<0.05);爬杆实验中小鼠爬完杆子上半部的计分:时间、干预方法在实验分值上存在统计学差异(P<0.05),B1组实验分值低于A组和B2组(P<0.05),B2组实验分值高于B4组(P<0.05);爬杆实验中小鼠爬完杆子的下半部的计分:时间、干预方法在实验分值上存在统计学差异(P<0.05),B1、B2、B3、B4组实验分值低于A组(P<0.05),B4组实验分值高于B1组(P<0.05)。悬挂实验计分:时间、干预方法在实验分值上存在统计学差异(P<0.05),B1、B2、B3、B4组实验分值均低于A组(P<0.05),B2、B3、B4组实验分值均高于B1组(P<0.05)。游泳实验计分:干预方法在实验分值上存在统计学差异(P<0.05),时间在实验分值上无统计学差异(P>0.05),B1组实验分值低于A组(P<0.05),B2组实验分值高于B1组(P<0.05)。所有实验结果中B2组与B3组间均不存在统计学差异(P>0.05)。结论骨化三醇、益生菌均可改善PD小鼠的行为学,两者联合应用未显示疗效,且两者间的有效性差异将有待进一步研究。 展开更多
关键词 帕金森病 骨化三醇 益生菌 行为学
下载PDF
骨化三醇辅助治疗血液透析继发甲状旁腺功能亢进患者的临床效果
10
作者 丘宝珍 朱兴华 +1 位作者 杜春荔 陈璐 《河北医科大学学报》 CAS 2024年第1期107-112,共6页
目的 观察骨化三醇辅助甲状旁腺微波消融治疗血液透析继发甲状旁腺功能亢进(hyperparathyroidism,SHPT)的临床效果。方法 选取血液透析SHPT患者82例,采用随机数字表法分为对照组(给予甲状旁腺微波消融+盐酸西那卡塞治疗,41例)和观察组(... 目的 观察骨化三醇辅助甲状旁腺微波消融治疗血液透析继发甲状旁腺功能亢进(hyperparathyroidism,SHPT)的临床效果。方法 选取血液透析SHPT患者82例,采用随机数字表法分为对照组(给予甲状旁腺微波消融+盐酸西那卡塞治疗,41例)和观察组(给予甲状旁腺微波消融+盐酸西那卡塞+骨化三醇治疗,41例)。比较2组甲状旁腺激素(parathyroid hormone,PTH)、碱性磷酸酶(alkaline phosphatase,ALP)、血磷、血钙水平、临床疗效、甲状旁腺腺体大小、肾功能指标[尿素氮(urea nitrogen,BUN)、血肌酐(serum creatinine,Scr)]、血清骨保护素(osteoprotectin,OPG)、成纤维细胞生长因子23(fibroblast growth factor 23,FGF-23)水平、不良反应发生情况、术中消融时间和输出功率。结果 治疗后,2组PTH、ALP、血磷水平均低于治疗前,血钙水平高于治疗前,观察组PTH、ALP、血磷水平均低于对照组,血钙水平高于对照组(P<0.05)。观察组总有效率血钙水平高于对照组(P<0.05)。2组甲状旁腺腺体纵径、横径、体积均低于治疗前,观察组甲状旁腺腺体纵径、横径、体积均低于对照组(P<0.05)。治疗后2组BUN、Scr水平比较差异无统计学意义(P>0.05)。2组OPG水平低于治疗前,FGF-23水平高于治疗前,观察组OPG、FGF-23水平低于对照组(P<0.05)。2组不良反应总发生率差异无统计学意义(P>0.05)。2组术中消融时间和输出功率比较差异无统计学意义(P>0.05)。结论 骨化三醇辅助甲状旁腺微波消融治疗血液透析SHPT患者效果较好。 展开更多
关键词 甲状旁腺功能亢进症 继发性 肾透析 骨化三醇
下载PDF
骨化三醇对老年骨质疏松性脊柱骨折病人PKP术后骨折愈合的影响
11
作者 叶恒 张卫华 +2 位作者 韩俊 张建业 李永鸿 《实用老年医学》 CAS 2024年第3期240-244,250,共6页
目的研究骨化三醇用于老年骨质疏松性椎体压缩性骨折(OVCF)病人经皮椎体后凸成形术(PKP)后治疗对骨折愈合和血清骨碱性磷酸酶(BALP)、Ⅰ型前胶原N-端前肽(PINP)、胶原羧基端肽β特殊序列(β-CTX)表达水平的影响。方法纳入2019—2020年... 目的研究骨化三醇用于老年骨质疏松性椎体压缩性骨折(OVCF)病人经皮椎体后凸成形术(PKP)后治疗对骨折愈合和血清骨碱性磷酸酶(BALP)、Ⅰ型前胶原N-端前肽(PINP)、胶原羧基端肽β特殊序列(β-CTX)表达水平的影响。方法纳入2019—2020年我院接受PKP手术的106例OVCF病人为研究对象,并采用随机数表法均分为观察组和对照组,每组53例。对照组PKP术后给予钙剂+阿仑膦酸钠片进行治疗,观察组在此基础上加用骨化三醇进行治疗,2组疗程均为6个月,比较2组临床疗效、Cobb角、Oswestry功能障碍指数(ODI)、骨密度和骨代谢指标的差异。结果2组治疗6个月有效率分别为90.57%和83.02%,差异无统计学意义(P>0.05),优良率分别为73.58%和52.83%,差异有统计学意义(P<0.05)。2组治疗1、3、6个月时Cobb角和ODI均明显低于治疗前(P<0.05),且观察组治疗6个月时ODI低于对照组,差异有统计学意义(P<0.05)。2组治疗3、6个月时骨密度均明显高于治疗前(P<0.05),且观察组治疗6个月时骨密度高于对照组,差异有统计学意义(P<0.05)。与治疗前相比,2组治疗1、3、6个月时BALP和PINP水平明显升高(P<0.05),β-CTX水平均明显降低(P<0.05),且观察组治疗1、3、6个月时BALP和PINP水平均高于对照组,差异有统计学意义(P<0.05)。结论OVCF病人PKP术后应用骨化三醇进行治疗具有良好效果,有利于改善骨代谢并增加骨密度,对促进骨折愈合、改善脊柱功能和提升日常生活能力具有积极作用。 展开更多
关键词 骨质疏松性椎体压缩性骨折 老年人 经皮椎体后凸成形术 骨化三醇 骨碱性磷酸酶 Ⅰ型前胶原N-端前肽 胶原羧基端肽β特殊序列
下载PDF
基于PI3K/Akt/mTOR信号通路探讨骨化三醇对闭合性腰椎压缩性骨折的干预效果
12
作者 黄震 王志伟 +1 位作者 陈杰 任冠瑞 《解剖学研究》 CAS 2024年第1期59-64,共6页
目的基于磷脂酰肌醇3⁃激酶(PI3K)/蛋白激酶B(Akt)/雷帕霉素靶蛋白(mTOR)信号通路,探讨骨化三醇对闭合性腰椎压缩性骨折的干预效果。方法选取我院2020年1月至2022年9月收治的150例闭合性腰椎压缩性骨折患者,按1∶1∶1比例分层随机分为空... 目的基于磷脂酰肌醇3⁃激酶(PI3K)/蛋白激酶B(Akt)/雷帕霉素靶蛋白(mTOR)信号通路,探讨骨化三醇对闭合性腰椎压缩性骨折的干预效果。方法选取我院2020年1月至2022年9月收治的150例闭合性腰椎压缩性骨折患者,按1∶1∶1比例分层随机分为空白组、对照组、观察组,每组各50人。3组均采取卧床静养、使用复位垫、硬板床、腰背肌训练、口服维D钙咀嚼片(规格750 mg×60 s),2片/次,1次/日治疗,空白组口服安慰剂胶囊,1粒/次,1次/日;对照组口服阿法骨化醇(规格0.25μg×20 s),2粒/次,1次/日;观察组口服骨化三醇胶囊(规格0.25μg×10 s),1粒/次,1次/日;各组均持续12周。评价治疗前后Os⁃westy功能障碍指数(ODI)和疼痛视觉模拟评分(VAS);检测PI3K/Akt/mTOR通路的蛋白表达;检测骨代谢指标:血清钙、血清磷、骨密度、骨钙素、碱性磷酸酶(ALP)、骨密度调节蛋白(OPG),RANK配体(RANKL)。结果治疗前3组VAS、ODI、骨密度、骨代谢指标、PI3K、Akt、mTOR蛋白表达水平差异无统计学意义(P>0.05)。治疗12周后,与空白组对比,对照组和观察组VAS评分、ODI指数、血清钙、RANKL指数及PI3K、Akt、mTOR蛋白表达水平显著降低,血清磷、ALP、骨密度、骨钙素、OPG指数升高,差异有统计学意义(P<0.05);与对照组相比,观察组ODI指数、VAS评分下降,骨密度、血清磷、ALP、骨钙素、OPG升高,血清钙、RANKL、PI3K、Akt、mTOR蛋白表达水平降低,差异有统计学意义(P<0.05)。结论骨化三醇可能通过对PI3K/Akt/mTOR通路双向调节作用:一方面激活PI3K/Akt/mTOR信号通路,促进骨折愈合;另一方面降低PI3K/Akt蛋白表达,抑制PI3K/Akt/mTOR信号通路,改善骨折导致炎症反应。 展开更多
关键词 腰椎压缩性骨折 骨化三醇 PI3K/Akt/mTOR信号通路
原文传递
骨化三醇联合碳酸钙胶囊治疗糖尿病性骨质疏松患者的疗效及安全性
13
作者 杨艳君 何启胜 刘君 《安徽医学》 2024年第1期44-47,共4页
目的分析骨化三醇联合碳酸钙胶囊对糖尿病性骨质疏松(DOP)患者疗效及安全性的影响。方法选取2021年1月至2022年5月池州市人民医院内分泌科收治的120例DOP患者为研究对象,依据随机数字表法分为对照组(n=60)和观察组(n=60),对照组给予碳... 目的分析骨化三醇联合碳酸钙胶囊对糖尿病性骨质疏松(DOP)患者疗效及安全性的影响。方法选取2021年1月至2022年5月池州市人民医院内分泌科收治的120例DOP患者为研究对象,依据随机数字表法分为对照组(n=60)和观察组(n=60),对照组给予碳酸钙胶囊治疗,观察组给予骨化三醇联合碳酸钙胶囊治疗。两组均治疗半年,比较两组临床疗效,治疗前后的骨密度、电解质代谢水平[血清钙(Ca)、磷(P)]及治疗期间用药副反应。结果观察组总有效率高于对照组(95.00%比83.33%),差异有统计学意义(P<0.05);两组副反应总发生率(3.33%比3.33%)差异无统计学意义(P=1.000)。与对照组相比,观察组治疗前后股骨粗隆、Wards三角区、股骨颈及腰椎L1~4部位骨密度差值和血Ca、P差值均较大(P<0.05)。结论骨化三醇联合碳酸钙胶囊可改善DOP患者疗效,增加骨密度,纠正电解质代谢水平,安全可靠。 展开更多
关键词 糖尿病性骨质疏松 骨化三醇 碳酸钙胶囊 骨密度 电解质代谢
下载PDF
骨化三醇胶丸联合胰激肽原酶对2型糖尿病微血管并发症患者外周血Hcy、RBP4、SAA水平的影响
14
作者 曾秀伟 尚士博 +1 位作者 赵艳荣 杨玲 《临床和实验医学杂志》 2024年第1期36-41,共6页
目的观察骨化三醇胶丸联合胰激肽原酶对2型糖尿病微血管并发症患者外周血同型半胱氨酸(Hcy)、视黄醇结合蛋白4(RBP4)、淀粉样蛋白A(SAA)水平的影响。方法前瞻性选取2020年1月至2022年12月秦皇岛市第二医院收治的104例2型糖尿病微血管并... 目的观察骨化三醇胶丸联合胰激肽原酶对2型糖尿病微血管并发症患者外周血同型半胱氨酸(Hcy)、视黄醇结合蛋白4(RBP4)、淀粉样蛋白A(SAA)水平的影响。方法前瞻性选取2020年1月至2022年12月秦皇岛市第二医院收治的104例2型糖尿病微血管并发症患者为对象,采用随机数字表法分为常规组(n=52)和骨化三醇组(n=52)。两组均接受利拉鲁肽治疗,常规组加用胰激肽原酶治疗,骨化三醇组在常规组基础上联合骨化三醇胶丸治疗。比较两组糖代谢(空腹血糖、餐后2 h血糖)、Hcy、RBP4、SAA、正五聚蛋白3(PTX3)及骨代谢指标[25-羟基维生素D(25(OH)D)、骨碱性磷酸酶(BAP)、骨保护素(OPG)、Ⅰ型前胶原氨基端延长肽(P1NP)、Ⅰ型前胶原氨基端延长肽(β-CTX)、碱性磷酸酶(ALP)]的水平差异,统计两组不良反应发生情况。结果治疗后,两组的空腹血糖、餐后2 h血糖均较治疗前降低,差异均有统计学意义(P<0.05);但骨化三醇组和常规组组间比较,差异均无统计学意义(P>0.05)。治疗后,骨化三醇组和常规组的Hcy、RBP4、SAA、PTX3水平均较治疗前降低,差异均有统计学意义(P<0.05),且骨化三醇组Hcy、RBP4、SAA、PTX3水平分别为(10.23±2.06)μmol/L、(32.85±5.15)mg/L、(23.01±3.86)μg/mL、(18.11±3.23)ng/mL,均低于常规组[(11.90±2.14)μmol/L、(37.25±6.58)mg/L、(29.23±3.74)μg/mL、(22.03±4.01)ng/mL],差异均有统计学意义(P<0.05)。治疗后,骨化三醇组25(OH)D、BAP、OPG水平均较治疗前升高,P1NP、β-CTX、ALP水平均较治疗前降低,差异均有统计学意义(P<0.05),常规组骨代谢指标治疗前后比较,差异均无统计学意义(P>0.05);骨化三醇组25(OH)D、BAP、OPG水平分别为(21.89±2.23)ng/mL、(38.98±4.74)μg/L、(312.52±34.41)ng/L,均高于常规组[(18.96±2.41)ng/mL、(31.52±4.06)μg/L、(279.96±31.04)ng/L],骨化三醇组P1NP、β-CTX、ALP水平分别为(41.66±4.26)ng/mL、(0.38±0.11)ng/mL、(5.08±0.89)U/L,均低于常规组[(45.89±5.01)ng/mL、(0.46±0.14)ng/mL、(6.61±1.21)U/L],差异均有统计学意义(P<0.05)。骨化三醇组高钙血症、头痛或头晕、胃肠道反应、皮疹、泌尿道感染等不良反应发生率为11.54%,与常规组的7.69%比较,差异无统计学意义(P>0.05)。结论骨化三醇胶丸联合胰激肽原酶治疗2型糖尿病微血管并发症可改善患者骨代谢指标,降低患者血清Hcy、RBP4、SAA、PTX3水平,且不增加不良反应。 展开更多
关键词 2型糖尿病 骨化三醇胶丸 胰激肽原酶 微血管并发症 骨代谢
下载PDF
Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediatedMAPK signaling 被引量:5
15
作者 Luwei He Huaguang Li +5 位作者 Chenyu Pan Yutong Hua Jiayin Peng Zhaocai Zhou Yun Zhao Moubin Lin 《Cancer Communications》 SCIE 2021年第8期726-746,共21页
Background:Colorectal cancer(CRC)is one of the most malignant tumorswith high incidence,yet its molecular mechanism is not fully understood,hindering the development of targeted therapy.Metabolic abnormalities are a h... Background:Colorectal cancer(CRC)is one of the most malignant tumorswith high incidence,yet its molecular mechanism is not fully understood,hindering the development of targeted therapy.Metabolic abnormalities are a hallmark of cancer.Targeting dysregulated metabolic features has become an important direction for modern anticancer therapy.In this study,we aimed to identify a new metabolic enzyme that promotes proliferation of CRC and to examine the related molecular mechanisms.Methods:We performed RNA sequencing and tissue microarray analyses of human CRC samples to identify new genes involved in CRC.Squalene epoxidase(SQLE)was identified to be highly upregulated in CRC patients.The regulatory function of SQLE in CRC progression and the therapeutic effect of SQLE inhibitors were determined by measuring CRC cell viability,colony and organoid formation,intracellular cholesterol concentration and xenograft tumor growth.Themolecularmechanism of SQLE functionwas explored by combining transcriptome and untargeted metabolomics analysis.Western blotting and realtime PCR were used to assess MAPK signaling activation by SQLE.Results:SQLE-related control of cholesterol biosynthesis was highly upregulated in CRC patients and associated with poor prognosis.SQLE promoted CRC growth in vitro and in vivo.Inhibition of SQLE reduced the levels of calcitriol(active form of vitamin D3)and CYP24A1,followed by an increase in intracellular Ca2+concentration.Subsequently,MAPK signaling was suppressed,resulting in the inhibition of CRC cell growth.Consistently,terbinafine,an SQLE inhibitor,suppressed CRC cell proliferation and organoid and xenograft tumor growth.Conclusions:Our findings demonstrate that SQLE promotes CRC through the accumulation of calcitriol and stimulation of CYP24A1-mediated MAPK signaling,highlighting SQLE as a potential therapeutic target for CRC treatment. 展开更多
关键词 calcitriol cell proliferation cholesterol biosynthesis colorectal cancer CYP24A1 MAPK signaling squalene epoxidase TERBINAFINE
原文传递
1,25(OH)_(2)D_(3)对小鼠皮肤创伤愈合的作用及机制研究
16
作者 母兴语 何小解 +3 位作者 黄诒洁 杭倩如 翁于格 丁艳 《皮肤性病诊疗学杂志》 2024年第3期147-156,共10页
目的探讨1,25(OH)_(2)D_(3)参与皮肤全层切割伤小鼠创面愈合的作用及机制。方法将40只5周龄C57BL/6雄性小鼠随机分为5组,包括皮肤创伤组、皮肤创伤+维生素D受体(VDR)抑制剂组、皮肤创伤+维生素D受体(VDR)激动剂组、皮肤创伤+维生素D药粉... 目的探讨1,25(OH)_(2)D_(3)参与皮肤全层切割伤小鼠创面愈合的作用及机制。方法将40只5周龄C57BL/6雄性小鼠随机分为5组,包括皮肤创伤组、皮肤创伤+维生素D受体(VDR)抑制剂组、皮肤创伤+维生素D受体(VDR)激动剂组、皮肤创伤+维生素D药粉(VD)组、正常对照组,每组8只。观察创面愈合情况,拍照并记录创面大小,计算创面愈合率。在创面处理第9天时,ELISA检测各组小鼠血清中1,25(OH)_(2)D_(3)的浓度;取创缘组织,HE染色检测创面组织病理变化,免疫荧光染色检测组织中VDR、CD31的表达情况,分别用qRT-PCR、Western Blot检测小鼠组织中VDR、Notch1、TNF-α、IL-17A、IL-17F和IL-22的mRNA和蛋白的表达。结果在小鼠伤口愈合第9天时,与正常对照组比较,皮肤创伤组血清1,25(OH)_(2)D_(3)浓度、创面组织VDR、CD31表达降低(P<0.05),TNF-α、IL-17A、IL-17F和IL-22表达升高,Notch1表达差异无统计学意义(P>0.05);与皮肤创伤组比较,皮肤创伤+VDR激动剂组、皮肤创伤+VD组小鼠皮肤创面愈合率、血清1,25(OH)_(2)D_(3)浓度、创面组织VDR、CD31、Notch1表达升高(P<0.05),创面组织TNF-α、IL-17A、IL-17F、和IL-22表达降低(P<0.05),皮肤创伤+VDR抑制剂组小鼠皮肤创面组织TNF-α、IL-22的蛋白表达升高(均P<0.01),创面愈合率、血清1,25(OH)_(2)D_(3)浓度、创面组织VDR、CD31、Notch1、TNF-α、IL-17A、IL-17F、IL-22的mRNA和Notch1、IL-17A、IL-17F的蛋白表达差异无统计学意义(P>0.05)。HE染色结果显示,皮肤创伤+VDR激动剂组、皮肤创伤+VD组小鼠的伤口组织炎性细胞浸润减轻且血管生成增加、真皮结缔组织较致密,表皮基本完成再上皮化。结论1,25(OH)_(2)D_(3)能够促进皮肤全层切割伤小鼠创面愈合,可能是通过减轻创面炎症因子TNF-α、IL-17A、IL-17F和IL-22的表达,促进Notch1受体和VDR的表达和血管生成实现的。 展开更多
关键词 骨化三醇 维生素D受体 Notch1受体 皮肤创伤愈合 炎症因子
下载PDF
骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进的疗效及安全性分析
17
作者 陈翠玲 陈丽玲 +2 位作者 汪剑云 罗玉钊 张水燕 《中国医药科学》 2024年第4期79-83,共5页
目的探讨骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进(SHPT)的治疗效果。方法选取2021年8月至2022年7月于高州市人民医院血液净化中心接受血液透析并发甲状旁腺功能亢进的患者80例,采用随机数表法分为观察组和对照组,每组各40例。在... 目的探讨骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进(SHPT)的治疗效果。方法选取2021年8月至2022年7月于高州市人民医院血液净化中心接受血液透析并发甲状旁腺功能亢进的患者80例,采用随机数表法分为观察组和对照组,每组各40例。在两组患者均维持透析治疗的基础上,对照组给予西那卡塞治疗,观察组给予骨化三醇联合西那卡塞治疗,两组均维持治疗6个月。比较两组临床疗效,收集治疗前后的全段甲状旁腺激素(iPTH)、甲状旁腺体积、血钙水平、血磷水平、钙磷乘积指标进行比较。结果治疗前,两组iPTH、甲状旁腺体积、血钙水平、血磷水平、钙磷乘积差异比较,差异无统计学意义(P>0.05);治疗后,观察组血钙水平高于对照组,iPTH、血磷水平均低于对照组,甲状旁腺体积小于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率优于对照组,差异有统计学意义(P<0.05)。结论骨化三醇联合西那卡塞治疗血液透析患者SHPT的临床效果显著,患者的血钙水平升高而iPTH、血磷水平均降低,甲状旁腺体积缩小,值得临床推广应用。 展开更多
关键词 继发性甲状旁腺功能亢进 骨化三醇 西那卡塞 全段甲状旁腺激素 血清钙 血清磷
下载PDF
尿毒症合并甲状旁腺功能亢进行骨化三醇联合西那卡塞治疗的临床疗效
18
作者 公超 韩一浩 +1 位作者 刘菲 李云云 《中国实用医药》 2024年第2期15-18,共4页
目的 分析尿毒症合并甲状旁腺功能亢进行骨化三醇联合西那卡塞治疗的临床疗效。方法 选择接受治疗的104例尿毒症合并甲状旁腺功能亢进患者,通过信封抽签方法分为观察组和对照组,每组52例。对照组行骨化三醇治疗,观察组行骨化三醇联合西... 目的 分析尿毒症合并甲状旁腺功能亢进行骨化三醇联合西那卡塞治疗的临床疗效。方法 选择接受治疗的104例尿毒症合并甲状旁腺功能亢进患者,通过信封抽签方法分为观察组和对照组,每组52例。对照组行骨化三醇治疗,观察组行骨化三醇联合西那卡塞治疗。比较两组患者治疗前后的肾功能指标(尿素氮、血肌酐)水平,甲状旁腺体积、甲状旁腺激素、血磷、血钙水平,血管钙化情况(心脏瓣膜钙化率、冠状动脉钙化评分),治疗后的临床疗效,用药过程中的不良反应发生情况。结果 治疗前以及治疗后,两组患者的尿素氮和血肌酐水平比较,差异均不明显(P>0.05)。治疗后,观察组患者的甲状旁腺体积、甲状旁腺激素、血磷、血钙水平分别为(1.15±0.15)cm^(3)、(287.64±54.32)ng/L、(1.66±0.23)mmol/L、(2.12±0.16)mmol/L,甲状旁腺体积减小,甲状旁腺激素、血磷、血钙水平均下降,且均小于对照组的(1.34±0.22)cm^(3)、(361.68±62.49)ng/L、(2.20±0.31)mmol/L、(2.43±0.29)mmol/L,差异明显(P<0.05)。对照组患者治疗后的甲状旁腺体积减小、甲状旁腺激素水平下降,差异明显(P<0.05)。观察组患者治疗后的心脏瓣膜钙化率42.31%、冠状动脉钙化评分(2.60±0.37)分均低于对照组的63.46%、(2.93±0.41)分,差异明显(P<0.05)。观察组患者治疗后获得了明显高于对照组的临床总有效率,组间比较差异明显(χ^(2)=4.981,P=0.026<0.05)。观察组和对照组用药过程中的不良反应发生率比较,差异不明显(χ^(2)=0.153,P=0.696>0.05)。结论 尿毒症合并甲状旁腺功能亢进通过骨化三醇联合西那卡塞治疗后显著改善了患者的血钙、血磷水平,促进甲状旁腺激素分泌明显减少,进而提高整体临床疗效。 展开更多
关键词 尿毒症 甲状旁腺功能亢进 西那卡塞 骨化三醇 血管钙化
下载PDF
骨化三醇联合西那卡塞治疗血液透析患者继发性甲状旁腺功能亢进的疗效
19
作者 魏芝薇 查白 周威 《中国医药指南》 2024年第4期76-79,共4页
目的 分析血液透析(MHD)患者继发性甲状旁腺功能亢进(SHPT)采取骨化三醇+西那卡塞治疗的效果。方法 选取2020年1月至2023年1月收治的60例MHD并发SHPT患者,随机分为观察组(骨化三醇+西那卡塞)和对照组(西那卡塞)各30例,对比效果。结果 ... 目的 分析血液透析(MHD)患者继发性甲状旁腺功能亢进(SHPT)采取骨化三醇+西那卡塞治疗的效果。方法 选取2020年1月至2023年1月收治的60例MHD并发SHPT患者,随机分为观察组(骨化三醇+西那卡塞)和对照组(西那卡塞)各30例,对比效果。结果 治疗前后,两组患者临床症状发生情况、肾功能指标组间对比差异均无统计学意义(P>0.05)。治疗前,两组实验室指标、甲状旁腺大小、甲状腺激素水平对比差异无统计学意义(P>0.05);治疗后,观察组实验室指标优于对照组,甲状旁腺体积小于对照组,甲状腺激素水平低于对照组(均P<0.05)。结论 骨化三醇与西那卡塞联合对MHD并发SHPT患者治疗可有效改善临床症状,抑制病情发展,价值较高。 展开更多
关键词 继发性甲状旁腺功能亢进 西那卡塞 肾功能 骨化三醇 甲状腺激素
下载PDF
维生素D补充对早产儿骨代谢及体液免疫功能的影响
20
作者 彭晓瑞 方玉玲 +1 位作者 胡艳 松邹晴 《中国药物与临床》 CAS 2024年第4期238-242,共5页
目的探讨维生素D补充对早产儿骨代谢及体液免疫功能的影响。方法根据随机数字表法,将在2021年1月至2023年1月于许昌市妇幼保健院出生的63例早产儿分为对照组(31例)和观察组(32例)。对照组给予常规吸氧、保暖等治疗,并使用早产儿专属的... 目的探讨维生素D补充对早产儿骨代谢及体液免疫功能的影响。方法根据随机数字表法,将在2021年1月至2023年1月于许昌市妇幼保健院出生的63例早产儿分为对照组(31例)和观察组(32例)。对照组给予常规吸氧、保暖等治疗,并使用早产儿专属的配方奶粉喂养;观察组在保持上述基础治疗的同时联合维生素D补充治疗。比较2组治疗前后的生长发育指标、骨代谢指标、免疫球蛋白水平及T细胞亚群。结果经治疗2组早产儿身长、体质量、骨密度均增加,且观察组[(47±4)cm、(3.2±0.7)kg、(2890±344)g/cm^(2)]较对照组[(45±3)cm、(2.8±0.5)kg、(2315±319)g/cm^(2)]增幅更大(P<0.05)。对照组早产儿血清磷、血清钙、血清25-羟维生素D、血清碱性磷酸酶水平治疗前后比较差异均无统计学意义(P>0.05);观察组治疗后早产儿的血清磷水平(1.89±0.09)mmol/L降低,且低于对照组(2.07±0.10)mmol/L;血清钙、血清25-羟维生素D、血清碱性磷酸酶[(2.25±0.27)mmol/L、(32±6)nmol/L、(437±35)U/L]均升高,且高于对照组[(2.06±0.12)mmol/L、(26±4)nmol/L、(266±45)U/L](P<0.05)。2组早产儿治疗前后免疫球蛋白A、免疫球蛋白M、免疫球蛋白G水平比较差异均无统计学意义(P>0.05)。对照组早产儿CD3^(+)、CD4^(+)、CD8^(+)水平治疗前后比较均差异无统计学意义(P>0.05);治疗后观察组早产儿的CD3^(+)、CD4^(+)、CD8^(+)水平均升高,且CD3^(+)、CD4^(+)水平[(70±5)%、(40±3)%]高于对照组[(64±4)%、(36±3)%](P<0.05);但2组CD8^(+)水平比较差异无统计学意义(P>0.05)。结论维生素D补充可有效促进早产儿生长发育及骨密度的增加,改善早产儿的骨代谢水平与钙磷代谢,增强细胞免疫功能,但对免疫球蛋白水平的影响有待进一步观察。 展开更多
关键词 婴儿 早产 骨骼 骨化三醇 免疫 体液 骨密度
下载PDF
上一页 1 2 41 下一页 到第
使用帮助 返回顶部